A Case of Post-Essential Thrombocythemia Myelofibrosis with Severe Osteosclerosis
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Essential thrombocythemia (ET) is a chronic myeloproliferative neoplasm that involves primarily the megakaryocytic lineage. After many years, a few patients with ET may develop bone marrow (BM) fibrosis and rarely develop osteosclerosis. A 60-yr-old female was admitted due to severe left upper quadrant abdominal discomfort. She had been diagnosed as ET 19 yrs ago. On liver computed tomography severe splenomegaly was shown. Laboratory tests revealed WBC 24.3×109/L, hemoglobin 13.4 g/dL, platelets 432×109/L, lactate dehydrogenase 4,065 IU/L (reference range;240-480). Blood smear demonstrated leukoerythroblastosis, teardrop cells, and giant and hypogranular platelets. BM study revealed inadequate aspirate due to dry tap. BM biopsy showed clusters of dysplastic megakaryocytes, grade 3 fibrosis, and severe osteosclerosis. Major/minor BCR-ABL1rearrangement and JAK2 V617F mutation were not detected. Cytogenetic studies revealed normal karyotype. According to the 2008 WHO diagnostic criteria, the patient was diagnosed as having post-essential thrombocythemia myelofibrosis with severe osteosclerosis. (Korean J Lab Med 2010;30:122-5)
Abstract
Essential thrombocythemia (ET) is a chronic myeloproliferative neoplasm that involves primarily the megakaryocytic lineage. After many years, a few patients with ET may develop bone marrow (BM) fibrosis and rarely develop osteosclerosis. A 60-yr-old female was admitted due to severe left upper quadrant abdominal discomfort. She had been diagnosed as ET 19 yrs ago. On liver computed tomography severe splenomegaly was shown. Laboratory tests revealed WBC 24.3×109/L, hemoglobin 13.4 g/dL, platelets 432×109/L, lactate dehydrogenase 4,065 IU/L (reference range;240-480). Blood smear demonstrated leukoerythroblastosis, teardrop cells, and giant and hypogranular platelets. BM study revealed inadequate aspirate due to dry tap. BM biopsy showed clusters of dysplastic megakaryocytes, grade 3 fibrosis, and severe osteosclerosis. Major/minor BCR-ABL1rearrangement and JAK2 V617F mutation were not detected. Cytogenetic studies revealed normal karyotype. According to the 2008 WHO diagnostic criteria, the patient was diagnosed as having post-essential thrombocythemia myelofibrosis with severe osteosclerosis. (Korean J Lab Med 2010;30:122-5)
참고문헌 (16)
- Bain BJ, "Bone marrow pathology. 3rd ed", pp.468~469 (2001), Blackwell Science
- Buhr T, "Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification", Pathol Res Pract, 189, pp.121~132 (1993)
- Thiele J, "Follow-up examinations including sequential bone marrow biop sies in essential thrombocythemia (ET): a retrospective clinicopathological study of 120 patients", Am J Hematol, 70, pp.283~291 (2002)
- Kreft A, "The incidence of myelofibrosis in essential thrombocythaemia, polycythaemia vera and chronic idiopathic myelofibrosis: a retrospective evaluation of sequential bone marrow biopsies", Acta Haematol, 113, pp.137~143 (2005)
- Passamonti F, "Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients", Haematologica, 93, pp.1645~1651 (2008)
- Thiele J, "Essential thrombocythaemia. In: Swerdlow SH, Campo E, et al. eds. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed", pp.48~50 (2008), IARC
- Cervantes F, "Myelofibrosis with myeloid metaplasia following essential thrombocythaemia:actuarial probability, presenting characteristics and evolution in a series of 195 patients", Br J Haematol, 118, pp.786~790 (2002)
- Kvasnicka HM, "The impact of clinicopathological studies on staging and survival in essential thrombocythemia, chronic idiopathic myelofibrosis, and polycythemia rubra vera", Semin Thromb Hemost, 32, pp.362~371 (2006)
- Thiele J, "Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients", Ann Hematol, 82, pp.148~152 (2003)
- Thiele J, "Clinicopathological criteria for differential diagnosis of thrombocythemias in various myeloproliferative disorders", Semin Thromb Hemost, 32, pp.219~230 (2006)
- Tefferi A, "Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel", Blood, 110, pp.1092~1097 (2007)
- Barosi G, "Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment", Leukemia, 22, pp.437~438 (2008)
- 이창규, "골경화증을 동반한 다발성 골수종 1예", 대한임상병리학회지, 11, pp.103~108 (1991)
- 송상훈, "호지킨 림프종에서 심한 골경화증을 동반한 골수침범 1예", The Korean Journal of Laboratory Medicine, 25(1), pp.24~27 (2005), 대한진단검사의학회
- Tefferi A, "Pathogenesis of myelofibrosis with myeloid metaplasia", J Clin Oncol, 23, pp.8520~8530 (2005)
- Andrieux J, "Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosis", Cancer Genet Cytogenet, 178, pp.11~16 (2007)